PATENT CLAIM ANALYSIS

Application Number: 15750716
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
The invention provides human antibodies against rabies and methods of using the same.

Claim (Index 6):
The antibody of  claim 5 , wherein the VL domain further comprises the following light chain variable region FRs:\n (a) an FR-L1 comprising the amino acid sequence of EIVLTQSPGTLSLSPGERATLSC (SEQ ID NO: 11); (b) an FR-L2 comprising the amino acid sequence of WYQQKPGQAPRLLIY (SEQ ID NO: 12); (c) an FR-L3 comprising the amino acid sequence of GIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC (SEQ ID NO: 13); and (d) an FR-L4 comprising the amino acid sequence of FGQGTKLEIK (SEQ ID NO: 14).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11890317', '12767182', '14402644', '11590126', '11978742']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7486170452615926
- 35 USC 102 Novelty (BERT): 0.548784996313706
- Combined Prediction Score: 0.7286338403668039
- Mean Citation Score: 393.69787600000006
- Max Citation Score: 448.26633
- Similarity Product: 234.2353126532436

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test